Cordlife Group Limited
Prices are adjusted according to historical splits.
- Today's Low:
- Today's High:
- Open Price:
- 52W Low:
- 52W High:
- Prev. Close:
- Market Cap.:
- $65.13 million
- Book Value:
- Revenue TTM:
- $55.16 million
- Operating Margin TTM:
- Gross Profit TTM:
- $37.19 million
- Profit Margin:
- Return on Assets TTM:
- Return on Equity TTM:
Cordlife Group Limited had its IPO on under the ticker symbol CLIFF.
The company operates in the Healthcare sector and Diagnostics & Research industry. Cordlife Group Limited has a staff strength of 0 employees.
Shares of Cordlife Group Limited opened at $0.25 at the start of the last trading session i.e. 2023-03-31.
The stocks traded within a range of $0.25 - $0.25, and closed at $0.25.
This is a 0% increase from the previous day's closing price.
A total volume of 0 shares were traded at the close of the day’s session.
In the last one week, shares of Cordlife Group Limited have increased by 0%.
Cordlife Group Limited's Key Ratios
Cordlife Group Limited has a market cap of $65.13 million, indicating a price to book ratio of 0.5685 and a price to sales ratio of 1.0369.
In the last 12-months Cordlife Group Limited’s revenue was $55.16 million with a gross profit of $37.19 million and an EBITDA of $4.65 million. The EBITDA ratio measures Cordlife Group Limited's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Cordlife Group Limited’s operating margin was 1.75% while its return on assets stood at 0.26% with a return of equity of 3.61%.
In Q4, Cordlife Group Limited’s quarterly earnings growth was a negative -17.7% while revenue growth was a negative 13.7%.
Cordlife Group Limited’s PE and PEG Ratio
- Forward PE
- Trailing PE
Its diluted EPS in the last 12-months stands at $0.02 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Cordlife Group Limited’s profitability.
Cordlife Group Limited stock is trading at a EV to sales ratio of 0.1481 and a EV to EBITDA ratio of 0.809. Its price to sales ratio in the trailing 12-months stood at 1.0369.
Cordlife Group Limited stock pays annual dividends of $0 per share, indicating a yield of 2.58% and a payout ratio of 41.67%.
Balance sheet and cash flow metrics
- Total Assets
- $18.76 billion
- Total Liabilities
- $3.55 billion
- Operating Cash Flow
- Capital Expenditure
- $227 million
- Dividend Payout Ratio
Cordlife Group Limited ended 2023 with $18.76 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $18.76 billion while shareholder equity stood at $7.79 billion.
Cordlife Group Limited ended 2023 with $590.00 million in deferred long-term liabilities, $3.55 billion in other current liabilities, 66000000.00 in common stock, $1.33 billion in retained earnings and $0 in goodwill. Its cash balance stood at $26.00 million and cash and short-term investments were $26.00 million. The company’s total short-term debt was $0 while long-term debt stood at $4.25 billion.
Cordlife Group Limited’s total current assets stands at $7.42 billion while long-term investments were $0 and short-term investments were $0. Its net receivables were $1.96 billion compared to accounts payable of $2.62 billion and inventory worth $5.13 billion.
In 2023, Cordlife Group Limited's operating cash flow was $-209000000.00 while its capital expenditure stood at $227 million.
Comparatively, Cordlife Group Limited paid $0.42 in dividends in 2023.
Other key metrics
- Current Trading Price
- 52-Week High
- 52-Week Low
- Analyst Target Price
Cordlife Group Limited stock is currently trading at $0.25 per share. It touched a 52-week high of $0.2778 and a 52-week low of $0.2778. Analysts tracking the stock have a 12-month average target price of $.
Its 50-day moving average was $0.25 and 200-day moving average was $0.25 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 6541.3% of the company’s stock are held by insiders while 677.8% are held by institutions.
Frequently Asked Questions About Cordlife Group Limited
Similar Industry Stocks (Diagnostics & Research)
Cordlife Group Limited, an investment holding company, provides cord blood banking services in Singapore, Hong Kong, India, Malaysia, the Philippines, and internationally. The company operates through two segments, Banking and Diagnostics. It provides cord blood, cord lining, and cord tissue banking services comprising processing and storage of stem cells; and non-invasive prenatal testing, paediatric vision screening, newborn metabolic screening, and newborn genetic screening services. The company also offers preimplantation genetic screening, endometrial receptivity test, paediatric allergen test, and genetic talent test services, as well as moms up, a mobile app for pregnancy and parenting resources. In addition, it provides management, marketing, and property investment services. Cordlife Group Limited was incorporated in 2001 and is headquartered in Singapore.